Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2018

01-10-2018 | Case Report

A case of an elderly female with diffuse hepatic hemangiomatosis complicated with multiple organic dysfunction and Kasabach–Merritt syndrome

Authors: Yoshiaki Shimizu, Takuya Komura, Takuya Seike, Hitoshi Omura, Tatsuo Kumai, Takashi Kagaya, Hajime Ohta, Atsuhiro Kawashima, Kenichi Harada, Shuichi Kaneko, Masashi Unoura

Published in: Clinical Journal of Gastroenterology | Issue 5/2018

Login to get access

Abstract

Since diffuse hepatic hemangiomatosis (DHH) is an extremely rare disease especially in adults, the etiology and natural course of adult-onset DHH has not been well understood. We report a case of DHH complicated with multiple organic dysfunction and Kasabach–Merritt syndrome (KMS) in an 83-year-old female. She presented with mild abdominal distension and laboratory findings revealed thrombocytopenia and abnormal coagulation, indicating disseminated intravascular coagulation (DIC). Enhanced computed tomography revealed diffuse, hypodense hepatic nodules with delayed enhancement involving the whole liver, and multiple hypodense splenic legions. To obtain a definitive diagnosis, laparoscopic-guided biopsy was performed. Histological findings revealed irregularly dilated non-anastomotic vascular spaces, which were lined with flat endothelial cells without cellular atypia. We diagnosed this as DHH complicated with splenic lesions and KMS. Although the patient was treated with symptomatic treatment, such as anti-coagulation therapy, hemangiomatous lesions, especially in the spleen, progressed rapidly, leading to worsening of DIC. Finally, the patient died of multiple organ failure at 12 months after diagnosis. A postmortem examination demonstrated diffuse hemangiomatosis of not only the liver and spleen, but also the adrenal glands and bone marrow. Despite no malignant histologically, DHH can be fatal if it progresses rapidly within a short period of time.
Literature
1.
go back to reference Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.PubMed Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.PubMed
2.
go back to reference Vilgrain V, Boulos L, Vullierme MP, et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20:379–97.CrossRefPubMed Vilgrain V, Boulos L, Vullierme MP, et al. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20:379–97.CrossRefPubMed
3.
go back to reference Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr. 1999;88:93–7.CrossRefPubMed Lopriore E, Markhorst DG. Diffuse neonatal haemangiomatosis: new views on diagnostic criteria and prognosis. Acta Paediatr. 1999;88:93–7.CrossRefPubMed
4.
go back to reference Jhaveri KS, Vlachou PA, Guindi M, et al. Association of hepatic hemangiomatosis with giant cavernous hemangioma in the adult population: prevalence, imaging appearance, and relevance. AJR Am J Roentgenol. 2011;196:809–15.CrossRefPubMed Jhaveri KS, Vlachou PA, Guindi M, et al. Association of hepatic hemangiomatosis with giant cavernous hemangioma in the adult population: prevalence, imaging appearance, and relevance. AJR Am J Roentgenol. 2011;196:809–15.CrossRefPubMed
5.
go back to reference Selmaier M, Cidlinsky K, Ell C, et al. Liver hemangiomatosis in Osler’s disease. Dtsch Med Wochenschr. 1993;118:1015–9.CrossRefPubMed Selmaier M, Cidlinsky K, Ell C, et al. Liver hemangiomatosis in Osler’s disease. Dtsch Med Wochenschr. 1993;118:1015–9.CrossRefPubMed
7.
go back to reference Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med. 2006;210:257–61.CrossRefPubMed Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med. 2006;210:257–61.CrossRefPubMed
8.
go back to reference Feurle GE. Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. Gastroenterology. 1990;99:258–62.CrossRefPubMed Feurle GE. Arteriovenous shunting and cholestasis in hepatic hemangiomatosis associated with metoclopramide. Gastroenterology. 1990;99:258–62.CrossRefPubMed
9.
go back to reference Yoo BR, Han HY, Choi SY, et al. Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography. 2014;33:65–70.CrossRefPubMed Yoo BR, Han HY, Choi SY, et al. Giant cavernous hemangioma coexistent with diffuse hepatic hemangiomatosis presenting as portal vein thrombosis and hepatic lobar atrophy. Ultrasonography. 2014;33:65–70.CrossRefPubMed
10.
go back to reference Batista A, Matos AP, Neta JO, et al. Diffuse hepatic hemangiomatosis in the adult without extra-hepatic involvement: an extremely rare occurrence. J Clin Imaging Sci. 2014;4:43.CrossRefPubMedPubMedCentral Batista A, Matos AP, Neta JO, et al. Diffuse hepatic hemangiomatosis in the adult without extra-hepatic involvement: an extremely rare occurrence. J Clin Imaging Sci. 2014;4:43.CrossRefPubMedPubMedCentral
11.
go back to reference Capilli F, Weinbeck M, Czerny M, et al. A rare case of diffuse hemangiomatosis of the spleen with splenic rupture following aortic valve replacement. Case Rep Radiol. 2017;2017:9164749.PubMedPubMedCentral Capilli F, Weinbeck M, Czerny M, et al. A rare case of diffuse hemangiomatosis of the spleen with splenic rupture following aortic valve replacement. Case Rep Radiol. 2017;2017:9164749.PubMedPubMedCentral
12.
go back to reference Militz M, Carlotto JR, Schmitz LD, et al. Diffuse hepatic hemangiomatosis of rapid growth after Bariatric surgery. Dig Liver Dis. 2016;48:1513.CrossRefPubMed Militz M, Carlotto JR, Schmitz LD, et al. Diffuse hepatic hemangiomatosis of rapid growth after Bariatric surgery. Dig Liver Dis. 2016;48:1513.CrossRefPubMed
13.
go back to reference Marinis A, Kairi E, Theodosopoulos T, et al. Right colon and liver hemangiomatosis: a case report and a review of the literature. World J Gastroenterol. 2006;12:6405–7.CrossRefPubMedPubMedCentral Marinis A, Kairi E, Theodosopoulos T, et al. Right colon and liver hemangiomatosis: a case report and a review of the literature. World J Gastroenterol. 2006;12:6405–7.CrossRefPubMedPubMedCentral
14.
go back to reference Kim EH, Park SY, Ihn YK, et al. Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient. Korean J Radiol. 2008;9:559–62.CrossRefPubMedPubMedCentral Kim EH, Park SY, Ihn YK, et al. Diffuse hepatic hemangiomatosis without extrahepatic involvement in an adult patient. Korean J Radiol. 2008;9:559–62.CrossRefPubMedPubMedCentral
15.
go back to reference Kim JD, Chang UI, Yang JM. Clinical challenges and images in GI. Diffuse hepatic hemangiomatosis involving the entire liver. Gastroenterology. 2008;134:1830 (2197).CrossRefPubMed Kim JD, Chang UI, Yang JM. Clinical challenges and images in GI. Diffuse hepatic hemangiomatosis involving the entire liver. Gastroenterology. 2008;134:1830 (2197).CrossRefPubMed
16.
go back to reference Liu X, Yang Z, Tan H, et al. Giant liver hemangioma with adult Kasabach–Merritt syndrome: case report and literature review. Medicine (Baltimore). 2017;96:e7688.CrossRef Liu X, Yang Z, Tan H, et al. Giant liver hemangioma with adult Kasabach–Merritt syndrome: case report and literature review. Medicine (Baltimore). 2017;96:e7688.CrossRef
17.
go back to reference Mahajan D, Miller C, Hirose K, et al. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008;49:867–70.CrossRefPubMed Mahajan D, Miller C, Hirose K, et al. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008;49:867–70.CrossRefPubMed
18.
go back to reference Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210–3.CrossRefPubMed Mitchell A, Adams LA, MacQuillan G, et al. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia. Liver Transpl. 2008;14:210–3.CrossRefPubMed
19.
go back to reference Toro A, Mahfouz AE, Ardiri A, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327–39.PubMed Toro A, Mahfouz AE, Ardiri A, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014;13:327–39.PubMed
20.
go back to reference Tsukagoshi H, Iwasaki Y, Toyoda M, et al. An autopsy case of systemic hemangiomatosis with honeycomb-like liver and focal splenic sarcomatoid changes. Intern Med. 1998;37:847–52.CrossRefPubMed Tsukagoshi H, Iwasaki Y, Toyoda M, et al. An autopsy case of systemic hemangiomatosis with honeycomb-like liver and focal splenic sarcomatoid changes. Intern Med. 1998;37:847–52.CrossRefPubMed
Metadata
Title
A case of an elderly female with diffuse hepatic hemangiomatosis complicated with multiple organic dysfunction and Kasabach–Merritt syndrome
Authors
Yoshiaki Shimizu
Takuya Komura
Takuya Seike
Hitoshi Omura
Tatsuo Kumai
Takashi Kagaya
Hajime Ohta
Atsuhiro Kawashima
Kenichi Harada
Shuichi Kaneko
Masashi Unoura
Publication date
01-10-2018
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 5/2018
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0871-3

Other articles of this Issue 5/2018

Clinical Journal of Gastroenterology 5/2018 Go to the issue